A brief intervention to help regular cannabis users manage stress
Refinement and Testing of a Brief Computerized and Smart Phone-based Intervention for Stress in Regular Cannabis Users
This study is testing a short, online program to help regular cannabis users manage their stress better and reduce their cannabis use.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 30 Years |
| Sex | All |
| Sponsor | Florida State University Academic / other |
| Locations | 1 site (Tallahassee, Florida) |
| Trial ID | NCT06085222 on ClinicalTrials.gov |
What this trial studies
This project evaluates a condensed, one-session computerized intervention aimed at reducing distress intolerance in individuals with Cannabis Use Disorder (CUD). The intervention incorporates an imaginal exposure module designed to enhance emotional engagement and utilizes just-in-time text message reminders based on real-time distress reports. By optimizing an existing intervention, the study seeks to assess its effectiveness in improving emotional regulation and reducing cannabis use outcomes through a randomized controlled trial. The approach is intended to be accessible and low-cost, targeting a high-risk population for significant public health impact.
Who should consider this trial
Good fit: Ideal candidates are individuals with a current diagnosis of Cannabis Use Disorder who use cannabis nearly daily and exhibit clinical-level distress intolerance.
Not a fit: Patients with acute psychiatric disturbances, those currently pregnant, or individuals planning to quit cannabis immediately may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce cannabis use and improve emotional regulation for individuals struggling with Cannabis Use Disorder.
How similar studies have performed: Other studies have shown promise with similar computerized interventions for substance use disorders, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cannabis is the primary substance of abuse. * Clinical-level Distress intolerance Index score. * Current Cannabis Use Disorder diagnosis. * Near-daily to daily cannabis use in past-month and past 3 months. * Positive urine screen for THC * Detectable skin conductance level * Owns a smart phone * Primary smoked/vaporized delta-9 or delta-8 THC user Exclusion Criteria: * Presence of acute/major psychiatric disturbance * Current pregnancy * Change in psychotropic medication within the past month * Concurrently receiving treatment for cannabis use * Concurrently receiving dialectical behavior therapy or exposure-based therapy for emotional disorders * Planning to immediately quit using cannabis * EEG contraindications * Kidney disease
Where this trial is running
Tallahassee, Florida
- The BRAINS Lab at Florida State University — Tallahassee, Florida, United States (Recruiting)
Study contacts
- Principal investigator: Richard J Macatee, PhD — Florida State University
- Study coordinator: Zoe Howell Project Coordinator, BS
- Email: brains@psy.fsu.edu
- Phone: 850-644-2445
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.